fintopic.
Docs Get the API

Johnson & Johnson enters definitive agreement to acquire Ollin Biosciences

8 statements from 5 sources, Nov 15, 2026 23:54 UTC to Nov 16, 2026 14:03 UTC
Part of Deals & M&A
News
Updated
JNJ
Front page

Statements (8)

  1. Neutral

    Johnson & Johnson agreed to acquire Ollin Biosciences for $2.2 billion upfront.

    nasdaq.comHigh importance
  2. Bullish

    Johnson & Johnson announced a deal to acquire Ollin Biosciences for up to $3.3 billion

    endpoints.newsHigh importance
  3. Bullish

    Johnson & Johnson announced it will acquire Ollin Biosciences Inc. for up to $3.3 billion.

    breakingthenews.netHigh importance
  4. Neutral

    Ollin Biosciences is being acquired by Johnson & Johnson for $2.2 billion upfront.

    businesswire.comHigh importance
  5. Bullish

    Johnson & Johnson entered into a definitive agreement to acquire Ollin Biosciences for $2.2 billion upfront.

    businesswire.comHigh importance
  6. Bullish

    Johnson & Johnson is close to acquiring Ollin Biosciences in a deal valued at up to $3.4 billion.

    nasdaq.comHigh importance
  7. Neutral

    Johnson & Johnson is considering acquiring Ollin Biosciences for $3.4 billion

    breakingthenews.netHigh importance
  8. Neutral

    Johnson & Johnson is looking to acquire Ollin Biosciences for up to $3.4 billion

    ft.comHigh importance